Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls

Bone

Volumn 52, Issue 1, 2013, Pages 389-392

  Schilcher, Jörg ^a   Koeppen, Veronika ^a,b   Ranstam, Jonas ^c   Skripitz, Ralf ^b   Michaëlsson, Karl ^d   Aspenberg, Per ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^c LUND UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Atypical femoral fracture; Bisphosphonate; Osteoporosis; Stress fracture

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ARTICLE; ATYPICAL FEMUR FRACTURE; BONE RADIOGRAPHY; CALLUS; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FEMUR FRACTURE; FEMUR SHAFT; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STRESS FRACTURE;

CASE-CONTROL STUDIES; FEMORAL FRACTURES; HUMANS; SWEDEN;

EID: 84868651511     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.10.016     Document Type: Article

References (12)

1. Tjhia C.K., Odvina C.V., Rao D.S., Stover S.M., Wang X., Fyhrie D.P. Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects. Bone 2011, 49:1279-1289.
2. Donnelly E., Meredith D.S., Nguyen J.T., Gladnick B.P., Rebolledo B.J., Shaffer A.D., et al. Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res 2012, 27:672-678.
3. Tang S.Y., Allen M.R., Phipps R., Burr D.B., Vashishth D. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int 2009, 20:887-894.
4. Schilcher J., Michaëlsson K., Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 2011, 364:1728-1737.
5. Shane E., Burr D., Ebeling P.R., Abrahamsen B., Adler R.A., Brown T.D., et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the american society for bone and mineral Research. J Bone Miner Res 2010, 25:2267-2294.
6. Feldstein A.C.A., Black D.D., Perrin N.N., Rosales A.G.A., Friess D.D., Boardman D.D., et al. Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res 2012, 27:977-986.
7. Girgis C.M., Sher D., Seibel M.J. Atypical femoral fractures and bisphosphonate use. N Engl J Med 2010, 362(19):1848-1849. [13].
8. Müller M.E., Nazarian S., Koch P., Schatzker J., Heim U. The Comprehensive Classification of Fractures of Long Bones 1994, Springer. 1st ed.
9. McLachlan G., Peel D. Finite Mixture Models 2000, John Wiley & Sons, Inc.
10. Moran D.S., Evans R.K., Hadad E. Imaging of lower extremity stress fracture injuries. Sports Med 2008, 38:345-356.
11. Rosenberg Z.S., La Rocca Vieira R., Chan S.S., Babb J., Akyol Y., Rybak L.D., et al. Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography. Am J Roentgenol 2011, 197:954-960.
12. Dell R.M., Adams A.L., Greene D.F., Funahashi T.T., Silverman S.L., Eisemon E.O., et al. Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 2012, [Epub ahead of print].